Skip to main content
HR 2666 118th Congress House Health Administrative law and regulatory procedures Congressional oversight Department of Health and Human Services Government studies and investigations Health care costs and insurance Intergovernmental relations Medicaid Prescription drugs

MVP Act

Introduced: November 7, 2023 Introduced by: Guthrie, Brett Republican · Kentucky See on congress.gov
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 12 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 19, 2024
Committee on Ways and Means discharged.
Dec 19, 2024
Placed on the Union Calendar, Calendar No. 768.
Dec 17, 2024
Referred to the Subcommittee on Work and Welfare.
Nov 18, 2024
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-743, Part I.
Nov 18, 2024
House Committee on Ways and Means Granted an extension for further consideration ending not later than Dec. 19, 2024.
May 24, 2023
Ordered to be Reported (Amended) by the Yeas and Nays: 31 - 19.
May 24, 2023
Committee Consideration and Mark-up Session Held.
May 17, 2023
Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 16 - 11 .
May 17, 2023
Subcommittee Consideration and Mark-up Session Held.
May 15, 2023
Referred to the Subcommittee on Health.
Apr 18, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 18, 2023
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Medicaid VBPs for Patients Act or the MVP Act

This bill provides statutory authority for regulations that allow for the use of varying best price points under value-based purchasing arrangements for purposes of the Medicaid Drug Rebate Program. (Value-based purchasing arrangements refer to arrangements in which the price of a drug is linked to clinical outcomes; such arrangements are particularly used for new high-cost treatments, such as gene therapies.)

The Government Accountability Office must study the impact of value-based purchasing arrangements on federal health care programs, including with respect to the bill's changes.

Additionally, the bill (1) exempts sales of drugs that are made under value-based purchasing arrangements from calculations of the manufacturer average sales price for purposes of payments under Medicare medical services, if the manufacturer reports multiple best prices under Medicaid in accordance with the bill's changes; and (2) requires the Centers for Medicare & Medicaid Services to establish a program under which state Medicaid programs may cover drugs in inpatient settings via value-based purchasing arrangements.

The bill's changes terminate five years after enactment; any value-based purchasing arrangements that are in effect as of the date of termination continue to apply.

What's happening now December 19, 2024

Placed on the Union Calendar, Calendar No. 768.

 Bill text 2 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Lobbying activity 3

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

 Cosponsors 42
D
Strickland, Marilyn
Washington · Sep 24, 2024
R
Cammack, Kat
Florida · Jun 25, 2024
R
Van Duyne, Beth
Texas · Jun 25, 2024
R
Malliotakis, Nicole
New York · Apr 30, 2024
Steel, Michelle
· Apr 30, 2024
Duncan, Jeff
· Apr 16, 2024
R
Van Drew, Jefferson
New Jersey · Apr 9, 2024
Caraveo, Yadira
· Feb 28, 2024
R
Ciscomani, Juan
Arizona · Feb 9, 2024
R
Meuser, Daniel
Pennsylvania · Feb 5, 2024
R
Moolenaar, John R.
Michigan · Feb 5, 2024
R
Owens, Burgess
Utah · Jan 31, 2024
R
Scott, Austin
Georgia · Jan 11, 2024
R
Kelly, Mike
Pennsylvania · Jan 3, 2024
D
Ivey, Glenn
Maryland · Dec 22, 2023
Burgess, Michael
· Dec 14, 2023
Bucshon, Larry
· Dec 12, 2023
D
Davis, Donald G.
North Carolina · Dec 12, 2023
D
Harder, Josh
California · Dec 5, 2023
D
Pettersen, Brittany
Colorado · Nov 28, 2023
D
Mullin, Kevin
California · Nov 15, 2023
D
Huffman, Jared
California · Nov 14, 2023
Ferguson, A.
· Nov 7, 2023
D
Carter, Troy A.
Louisiana · Nov 6, 2023
D
Gottheimer, Josh
New Jersey · Nov 1, 2023
R
Carter, Earl L. "Buddy"
Georgia · Oct 2, 2023
D
Houlahan, Chrissy
Pennsylvania · Sep 14, 2023
D
Sherrill, Mikie
New Jersey · Aug 22, 2023
D
Thompson, Mike
California · Aug 1, 2023
D
Lieu, Ted
California · Jul 17, 2023
D
Bera, Ami
California · Jul 10, 2023
Phillips, Dean
· Jun 30, 2023
R
Balderson, Troy
Ohio · May 22, 2023
R
Dunn, Neal P.
Florida · May 17, 2023
R
Bilirakis, Gus M.
Florida · May 15, 2023
R
Crenshaw, Dan
Texas · May 11, 2023
D
Swalwell, Eric
California · May 11, 2023
D
Auchincloss, Jake
Massachusetts · Apr 18, 2023
Eshoo, Anna
· Apr 18, 2023
R
Joyce, John
Pennsylvania · Apr 18, 2023
R
Miller-Meeks, Mariannette
Iowa · Apr 18, 2023
D
Peters, Scott H.
California · Apr 18, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2666: Medicaid VBPs for Patients Act. 118th Congress. Open America. https://openamerica.io/bill/118-HR-2666/
MLA
"H.R. 2666: Medicaid VBPs for Patients Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-2666/.
Bluebook (legal)
H.R. 2666, 118th Cong. (2026), https://openamerica.io/bill/118-HR-2666/.
Markdown link
[H.R. 2666: Medicaid VBPs for Patients Act](https://openamerica.io/bill/118-HR-2666/)
Report a problem